GlassScriptPhysician profile
Kendall Lewis
NPI 1457811044
$1,143.99
in general payments reported to CMS, 2019-2025
19 companies · $599 in 2025
The $599 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $144 · 2024: $401 · 2025: $599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,143.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $324.26 | 2023-2025 | |
| Baxter Healthcare | $148.50 | 2024 | Tisseel |
| Biogen, INC. | $88.22 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $73.22 | 2024-2025 | Veozah |
| Optumhealth Care Solutions, LLC | $60.96 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Sumitomo Pharma America, INC. | $59.80 | 2023 | Myfembree |
| Hologic Sales and Service, LLC | $58.78 | 2024-2025 | Aptima, Fetal Fibronectin Enzyme Immunoassay |
| Exeltis, USA INC. | $57.90 | 2023-2025 | Slynd |
| Abbvie INC. | $57.15 | 2023-2025 | |
| Davol INC. | $42.21 | 2025 | Arista |
| Millicent US INC | $40.34 | 2024-2025 | Femlyv, Intrarosa |
| Pfizer INC. | $25.35 | 2024 | |
| Coopersurgical, INC. | $24.05 | 2024 | Wallach Cryosurgical Equipment |
| Abbott Laboratories | $19.09 | 2025 | Proclaim |
| Bayer Healthcare Pharmaceuticals INC. | $17.89 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hydrofera LLC | $17.33 | 2025 | Hydrofera Blue Ready - Border |
| Convatec INC. | $17.15 | 2024 | |
| Channel Medsystems, INC. | $9.58 | 2025 | |
| Aspira Women'S Health INC | $2.21 | 2024 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendall Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.